Skip to main content
Top
Published in: General Thoracic and Cardiovascular Surgery 3/2024

20-07-2023 | Metastasis | Original Article

CircRUNX1 drives the malignant phenotypes of lung adenocarcinoma through mediating the miR-5195-3p/HMGB3 network

Authors: Yan Wang, Hui Li, Wenbin Chen, Xiaoliang Huang, Renliang Fan, Meijia Xu, Li Zou

Published in: General Thoracic and Cardiovascular Surgery | Issue 3/2024

Login to get access

Abstract

Background

Circular RNAs (circRNAs) are key factors in the regulation of cancer progression. However, the role of circRUNX1 in lung adenocarcinoma (LUAD) progression is unclear.

Methods

The expression levels of circRUNX1, microRNA (miR)-5195-3p, and high-mobility group protein B3 (HMGB3) were detected by quantitative real-time PCR. Cell proliferation, migration, invasion and apoptosis were analyzed by EdU staining, colony formation assay, transwell assay and flow cytometry. Protein levels were measured using western blot analysis. The interaction between miR-5195-3p and circRUNX1 or HMGB3 was verified by dual-luciferase reporter assay and RIP assay. Animal experiments were performed to investigate the role of circRUNX1 in LUAD tumorigenesis.

Results

We found that circRUNX1 was upregulated in LUAD tumor tissues and cells. CircRUNX1 knockdown suppressed LUAD cell proliferation and metastasis, while promoted apoptosis. In terms of mechanism, we found that circRUNX1 could sponge miR-5195-3p, and miR-5195-3p inhibitor abolished the regulation of circRUNX1 knockdown on LUAD cell proliferation, metastasis and apoptosis. In addition, miR-5195-3p could target HMGB3, and HMGB3 overexpression reversed the inhibition effect of miR-5195-3p on LUAD progression. Moreover, circRUNX1 knockdown reduced LUAD tumorigenesis.

Conclusion

CircRUNX1 facilitated LUAD proliferation and metastasis by regulating the miR-5195-3p/HMGB3 axis, suggesting that it might be a possible therapeutic target for LUAD.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hutchinson BD, Shroff GS, Truong MT, Ko JP. Spectrum of lung adenocarcinoma. Semin Ultrasound CT MR. 2019;40(3):255–64.CrossRefPubMed Hutchinson BD, Shroff GS, Truong MT, Ko JP. Spectrum of lung adenocarcinoma. Semin Ultrasound CT MR. 2019;40(3):255–64.CrossRefPubMed
2.
go back to reference Pascoe HM, Knipe HC, Pascoe D, Heinze SB. The many faces of lung adenocarcinoma: a pictorial essay. J Med Imaging Radiat Oncol. 2018;62(5):654–61.CrossRefPubMed Pascoe HM, Knipe HC, Pascoe D, Heinze SB. The many faces of lung adenocarcinoma: a pictorial essay. J Med Imaging Radiat Oncol. 2018;62(5):654–61.CrossRefPubMed
3.
go back to reference Davies MM, Mathur P, Carnochan P, Saini S, Allen-Mersh TG. Effect of manipulation of primary tumour vascularity on metastasis in an adenocarcinoma model. Br J Cancer. 2002;86(1):123–9.CrossRefPubMedPubMedCentral Davies MM, Mathur P, Carnochan P, Saini S, Allen-Mersh TG. Effect of manipulation of primary tumour vascularity on metastasis in an adenocarcinoma model. Br J Cancer. 2002;86(1):123–9.CrossRefPubMedPubMedCentral
4.
go back to reference Radkiewicz C, Dickman PW, Johansson ALV, Wagenius G, Edgren G, Lambe M. Sex and survival in non-small cell lung cancer: a nationwide cohort study. PLoS ONE. 2019;14(6): e0219206.CrossRefPubMedPubMedCentral Radkiewicz C, Dickman PW, Johansson ALV, Wagenius G, Edgren G, Lambe M. Sex and survival in non-small cell lung cancer: a nationwide cohort study. PLoS ONE. 2019;14(6): e0219206.CrossRefPubMedPubMedCentral
5.
go back to reference Shiiba M, Unozawa M, Higo M, Kouzu Y, Kasamatsu A, Sakamoto Y, et al. Controlling distant metastasis and surgical treatment are crucial for improving clinical outcome in uncommon head and neck malignancies, such as non-squamous cell carcinoma. Mol Clin Oncol. 2014;2(4):609–17.CrossRefPubMedPubMedCentral Shiiba M, Unozawa M, Higo M, Kouzu Y, Kasamatsu A, Sakamoto Y, et al. Controlling distant metastasis and surgical treatment are crucial for improving clinical outcome in uncommon head and neck malignancies, such as non-squamous cell carcinoma. Mol Clin Oncol. 2014;2(4):609–17.CrossRefPubMedPubMedCentral
6.
go back to reference Song Q, Shang J, Yang Z, Zhang L, Zhang C, Chen J, et al. Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma. J Transl Med. 2019;17(1):70.CrossRefPubMedPubMedCentral Song Q, Shang J, Yang Z, Zhang L, Zhang C, Chen J, et al. Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma. J Transl Med. 2019;17(1):70.CrossRefPubMedPubMedCentral
8.
9.
go back to reference Hsiao KY, Sun HS, Tsai SJ. Circular RNA - New member of noncoding RNA with novel functions. Exp Biol Med (Maywood). 2017;242(11):1136–41.CrossRefPubMed Hsiao KY, Sun HS, Tsai SJ. Circular RNA - New member of noncoding RNA with novel functions. Exp Biol Med (Maywood). 2017;242(11):1136–41.CrossRefPubMed
11.
go back to reference Kristensen LS, Hansen TB, Veno MT, Kjems J. Circular RNAs in cancer: opportunities and challenges in the field. Oncogene. 2018;37(5):555–65.CrossRefPubMed Kristensen LS, Hansen TB, Veno MT, Kjems J. Circular RNAs in cancer: opportunities and challenges in the field. Oncogene. 2018;37(5):555–65.CrossRefPubMed
12.
go back to reference Zhang HD, Jiang LH, Sun DW, Hou JC, Ji ZL. CircRNA: a novel type of biomarker for cancer. Breast Cancer. 2018;25(1):1–7.CrossRefPubMed Zhang HD, Jiang LH, Sun DW, Hou JC, Ji ZL. CircRNA: a novel type of biomarker for cancer. Breast Cancer. 2018;25(1):1–7.CrossRefPubMed
14.
go back to reference Zhang SJ, Ma J, Wu JC, Hao ZZ, Zhang YN, Zhang YJ. CircRNA EPB41L2 inhibits tumorigenicity of lung adenocarcinoma through regulating CDH4 by miR-211-5p. Eur Rev Med Pharmacol Sci. 2020;24(7):3749–60.PubMed Zhang SJ, Ma J, Wu JC, Hao ZZ, Zhang YN, Zhang YJ. CircRNA EPB41L2 inhibits tumorigenicity of lung adenocarcinoma through regulating CDH4 by miR-211-5p. Eur Rev Med Pharmacol Sci. 2020;24(7):3749–60.PubMed
15.
go back to reference Xin T, Li S, Zhang Y, Kamali X, Liu H, Jia T. circRNA Hsa_circ_0020850 silence represses the development of lung adenocarcinoma via regulating miR-195-5p/IRS2 axis. Cancer Manag Res. 2020;12:10679–92.CrossRefPubMedPubMedCentral Xin T, Li S, Zhang Y, Kamali X, Liu H, Jia T. circRNA Hsa_circ_0020850 silence represses the development of lung adenocarcinoma via regulating miR-195-5p/IRS2 axis. Cancer Manag Res. 2020;12:10679–92.CrossRefPubMedPubMedCentral
16.
go back to reference Ma Y, Zhang X, Wang YZ, Tian H, Xu S. Research progress of circular RNAs in lung cancer. Cancer Biol Ther. 2019;20(2):123–9.CrossRefPubMed Ma Y, Zhang X, Wang YZ, Tian H, Xu S. Research progress of circular RNAs in lung cancer. Cancer Biol Ther. 2019;20(2):123–9.CrossRefPubMed
17.
go back to reference Chen ZL, Li XN, Ye CX, Chen HY, Wang ZJ. Elevated levels of circRUNX1 in colorectal cancer promote cell growth and metastasis via miR-145-5p/IGF1 signalling. Onco Targets Ther. 2020;13:4035–48.CrossRefPubMedPubMedCentral Chen ZL, Li XN, Ye CX, Chen HY, Wang ZJ. Elevated levels of circRUNX1 in colorectal cancer promote cell growth and metastasis via miR-145-5p/IGF1 signalling. Onco Targets Ther. 2020;13:4035–48.CrossRefPubMedPubMedCentral
18.
go back to reference Yu J, Chen X, Li J, Wang F. CircRUNX1 functions as an oncogene in colorectal cancer by regulating circRUNX1/miR-485-5p/SLC38A1 axis. Eur J Clin Invest. 2021;51(7): e13540.CrossRefPubMed Yu J, Chen X, Li J, Wang F. CircRUNX1 functions as an oncogene in colorectal cancer by regulating circRUNX1/miR-485-5p/SLC38A1 axis. Eur J Clin Invest. 2021;51(7): e13540.CrossRefPubMed
19.
go back to reference Chu J, Tao L, Yao T, Chen Z, Lu X, Gao L, et al. Circular RNA circRUNX1 promotes papillary thyroid cancer progression and metastasis by sponging MiR-296-3p and regulating DDHD2 expression. Cell Death Dis. 2021;12(1):112.CrossRefPubMedPubMedCentral Chu J, Tao L, Yao T, Chen Z, Lu X, Gao L, et al. Circular RNA circRUNX1 promotes papillary thyroid cancer progression and metastasis by sponging MiR-296-3p and regulating DDHD2 expression. Cell Death Dis. 2021;12(1):112.CrossRefPubMedPubMedCentral
20.
go back to reference Yan Y, Zhang R, Zhang X, Zhang A, Zhang Y, Bu X. RNA-Seq profiling of circular RNAs and potential function of hsa_circ_0002360 in human lung adenocarcinom. Am J Transl Res. 2019;11(1):160–75.PubMedPubMedCentral Yan Y, Zhang R, Zhang X, Zhang A, Zhang Y, Bu X. RNA-Seq profiling of circular RNAs and potential function of hsa_circ_0002360 in human lung adenocarcinom. Am J Transl Res. 2019;11(1):160–75.PubMedPubMedCentral
21.
go back to reference Kulcheski FR, Christoff AP, Margis R. Circular RNAs are miRNA sponges and can be used as a new class of biomarker. J Biotechnol. 2016;238:42–51.CrossRefPubMed Kulcheski FR, Christoff AP, Margis R. Circular RNAs are miRNA sponges and can be used as a new class of biomarker. J Biotechnol. 2016;238:42–51.CrossRefPubMed
22.
go back to reference Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK, et al. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495(7441):384–8.ADSCrossRefPubMed Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK, et al. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495(7441):384–8.ADSCrossRefPubMed
23.
go back to reference Wang J, Zhao X, Wang Y, Ren F, Sun D, Yan Y, et al. circRNA-002178 act as a ceRNA to promote PDL1/PD1 expression in lung adenocarcinoma. Cell Death Dis. 2020;11(1):32.CrossRefPubMedPubMedCentral Wang J, Zhao X, Wang Y, Ren F, Sun D, Yan Y, et al. circRNA-002178 act as a ceRNA to promote PDL1/PD1 expression in lung adenocarcinoma. Cell Death Dis. 2020;11(1):32.CrossRefPubMedPubMedCentral
24.
go back to reference Zhou J, Zhang S, Chen Z, He Z, Xu Y, Li Z. CircRNA-ENO1 promoted glycolysis and tumor progression in lung adenocarcinoma through upregulating its host gene ENO1. Cell Death Dis. 2019;10(12):885.CrossRefPubMedPubMedCentral Zhou J, Zhang S, Chen Z, He Z, Xu Y, Li Z. CircRNA-ENO1 promoted glycolysis and tumor progression in lung adenocarcinoma through upregulating its host gene ENO1. Cell Death Dis. 2019;10(12):885.CrossRefPubMedPubMedCentral
25.
go back to reference Liang Y, Wang H, Chen B, Mao Q, Xia W, Zhang T, et al. circDCUN1D4 suppresses tumor metastasis and glycolysis in lung adenocarcinoma by stabilizing TXNIP expression. Mol Ther Nucleic Acids. 2021;23:355–68.CrossRefPubMed Liang Y, Wang H, Chen B, Mao Q, Xia W, Zhang T, et al. circDCUN1D4 suppresses tumor metastasis and glycolysis in lung adenocarcinoma by stabilizing TXNIP expression. Mol Ther Nucleic Acids. 2021;23:355–68.CrossRefPubMed
26.
go back to reference Yao Y, Hua Q, Zhou Y. CircRNA has_circ_0006427 suppresses the progression of lung adenocarcinoma by regulating miR-6783-3p/DKK1 axis and inactivating Wnt/beta-catenin signaling pathway. Biochem Biophys Res Commun. 2019;508(1):37–45.CrossRefPubMed Yao Y, Hua Q, Zhou Y. CircRNA has_circ_0006427 suppresses the progression of lung adenocarcinoma by regulating miR-6783-3p/DKK1 axis and inactivating Wnt/beta-catenin signaling pathway. Biochem Biophys Res Commun. 2019;508(1):37–45.CrossRefPubMed
27.
go back to reference Jiang Z, Zhang Y, Cao R, Li L, Zhong K, Chen Q, et al. miR-5195-3p inhibits proliferation and invasion of human bladder cancer cells by directly targeting oncogene KLF5. Oncol Res. 2017;25(7):1081–7.CrossRefPubMedPubMedCentral Jiang Z, Zhang Y, Cao R, Li L, Zhong K, Chen Q, et al. miR-5195-3p inhibits proliferation and invasion of human bladder cancer cells by directly targeting oncogene KLF5. Oncol Res. 2017;25(7):1081–7.CrossRefPubMedPubMedCentral
29.
go back to reference Yang Q. MicroRNA-5195-3p plays a suppressive role in cell proliferation, migration and invasion by targeting MYO6 in human non-small cell lung cancer. Biosci Biotechnol Biochem. 2019;83(2):212–20.CrossRefPubMed Yang Q. MicroRNA-5195-3p plays a suppressive role in cell proliferation, migration and invasion by targeting MYO6 in human non-small cell lung cancer. Biosci Biotechnol Biochem. 2019;83(2):212–20.CrossRefPubMed
30.
go back to reference Li G, Li X, Yuan C, Zhou C, Li X, Li J, et al. Long non-coding RNA JPX contributes to tumorigenesis by regulating miR-5195-3p/VEGFA in non-small cell lung cancer. Cancer Manag Res. 2021;13:1477–89.CrossRefPubMedPubMedCentral Li G, Li X, Yuan C, Zhou C, Li X, Li J, et al. Long non-coding RNA JPX contributes to tumorigenesis by regulating miR-5195-3p/VEGFA in non-small cell lung cancer. Cancer Manag Res. 2021;13:1477–89.CrossRefPubMedPubMedCentral
31.
go back to reference Gu J, Xu T, Huang QH, Zhang CM, Chen HY. HMGB3 silence inhibits breast cancer cell proliferation and tumor growth by interacting with hypoxia-inducible factor 1alpha. Cancer Manag Res. 2019;11:5075–89.CrossRefPubMedPubMedCentral Gu J, Xu T, Huang QH, Zhang CM, Chen HY. HMGB3 silence inhibits breast cancer cell proliferation and tumor growth by interacting with hypoxia-inducible factor 1alpha. Cancer Manag Res. 2019;11:5075–89.CrossRefPubMedPubMedCentral
32.
go back to reference Zhang Z, Chang Y, Zhang J, Lu Y, Zheng L, Hu Y, et al. HMGB3 promotes growth and migration in colorectal cancer by regulating WNT/beta-catenin pathway. PLoS ONE. 2017;12(7): e0179741.CrossRefPubMedPubMedCentral Zhang Z, Chang Y, Zhang J, Lu Y, Zheng L, Hu Y, et al. HMGB3 promotes growth and migration in colorectal cancer by regulating WNT/beta-catenin pathway. PLoS ONE. 2017;12(7): e0179741.CrossRefPubMedPubMedCentral
33.
go back to reference Xie X, Pan J, Han X, Chen W. Downregulation of microRNA-532-5p promotes the proliferation and invasion of bladder cancer cells through promotion of HMGB3/Wnt/beta-catenin signaling. Chem Biol Interact. 2019;300:73–81.CrossRefPubMed Xie X, Pan J, Han X, Chen W. Downregulation of microRNA-532-5p promotes the proliferation and invasion of bladder cancer cells through promotion of HMGB3/Wnt/beta-catenin signaling. Chem Biol Interact. 2019;300:73–81.CrossRefPubMed
34.
go back to reference Xie Y, Wang L, Yang D. CircEPSTI1 promotes the progression of non-small cell lung cancer through miR-145/HMGB3 axis. Cancer Manag Res. 2020;12:6827–36.CrossRefPubMedPubMedCentral Xie Y, Wang L, Yang D. CircEPSTI1 promotes the progression of non-small cell lung cancer through miR-145/HMGB3 axis. Cancer Manag Res. 2020;12:6827–36.CrossRefPubMedPubMedCentral
35.
go back to reference Shi J, Wang H, Feng W, Huang S, An J, Qiu Y, et al. Long non-coding RNA HOTTIP promotes hypoxia-induced glycolysis through targeting miR-615-3p/HMGB3 axis in non-small cell lung cancer cells. Eur J Pharmacol. 2019;862:172615.CrossRefPubMed Shi J, Wang H, Feng W, Huang S, An J, Qiu Y, et al. Long non-coding RNA HOTTIP promotes hypoxia-induced glycolysis through targeting miR-615-3p/HMGB3 axis in non-small cell lung cancer cells. Eur J Pharmacol. 2019;862:172615.CrossRefPubMed
36.
go back to reference Zhang S, Liu J, Yuan T, Liu H, Wan C, Le Y. Circular RNA 0001313 knockdown suppresses non-small cell lung cancer cell proliferation and invasion via the microRNA-452/HMGB3/ERK/MAPK axis. Int J Gen Med. 2020;13:1495–507.CrossRefPubMedPubMedCentral Zhang S, Liu J, Yuan T, Liu H, Wan C, Le Y. Circular RNA 0001313 knockdown suppresses non-small cell lung cancer cell proliferation and invasion via the microRNA-452/HMGB3/ERK/MAPK axis. Int J Gen Med. 2020;13:1495–507.CrossRefPubMedPubMedCentral
37.
go back to reference Zhou ZF, Wei Z, Yao JC, Liu SY, Wang F, Wang Z, et al. CircRNA_102179 promotes the proliferation, migration and invasion in non-small cell lung cancer cells by regulating miR-330-5p/HMGB3 axis. Pathol Res Pract. 2020;216(11): 153144.CrossRefPubMed Zhou ZF, Wei Z, Yao JC, Liu SY, Wang F, Wang Z, et al. CircRNA_102179 promotes the proliferation, migration and invasion in non-small cell lung cancer cells by regulating miR-330-5p/HMGB3 axis. Pathol Res Pract. 2020;216(11): 153144.CrossRefPubMed
Metadata
Title
CircRUNX1 drives the malignant phenotypes of lung adenocarcinoma through mediating the miR-5195-3p/HMGB3 network
Authors
Yan Wang
Hui Li
Wenbin Chen
Xiaoliang Huang
Renliang Fan
Meijia Xu
Li Zou
Publication date
20-07-2023
Publisher
Springer Nature Singapore
Keyword
Metastasis
Published in
General Thoracic and Cardiovascular Surgery / Issue 3/2024
Print ISSN: 1863-6705
Electronic ISSN: 1863-6713
DOI
https://doi.org/10.1007/s11748-023-01960-5

Other articles of this Issue 3/2024

General Thoracic and Cardiovascular Surgery 3/2024 Go to the issue